Intramuscular methylprednisolone administration in hand osteoarthritis patients: a feasibility study to inform a randomized controlled trial.

Merel HartogKyra A L van KeekenCornelia H M van den EndeCalin D Popa

Published in: Therapeutic advances in musculoskeletal disease (2024)

We found a good acceptability of intramuscular methylprednisolone treatment among HCPs and HOA patients, as well as a potential to reduce pain and improve hand function with a good safety profile for as long as 12 weeks after a single administration.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
rheumatoid arthritis
patient reported outcomes
pain management
spinal cord
neuropathic pain